i am very familiar with qcom's licensing model...i was heavily invested in them many years ago...
qcom's chips were widely regarded as cutting edge tech and were highly sought after by companies all over the world...there was a time when no one could make a cell phone without them...and everyone paid dearly for the privilege...
kblb has a VERY limited amount of potential customers for their disease resistant worms...really, only a handful of countries...and of those, china and india make, by far, the lions share of silk...
im going to assume china will decline to license anything...india might also...whats left is pretty minimal...any money is good money at this point for kblb...but i dont see the licensing being as lucrative as some imagine...
its not the business model thats in question...licensing is a very good thing...but when you only have a very limited amount of potential licensing customers, it will be a nice revenue stream...just not lucrative...
Market Data 
Markets 
AI
